Is there any association between use of smokeless tobacco products and coronary heart disease in Bangladesh?

PLoS ONE

Volumn 7, Issue 1, 2012, Pages

  Rahman, Muhammad Aziz ^a   Spurrier, Nicola ^a   Mahmood, Mohammad Afzal ^a   Rahman, Mahmudur ^b   Choudhury, Sohel Reza ^c   Leeder, Stephen ^d  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b Institute of Epidemiology Disease Control and Research IEDCR   (Bangladesh)

^c National Heart Foundation Hospital Research Institute (NHFHRI)   (Bangladesh)

^d University of Sydney   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BANGLADESH; CARDIOVASCULAR RISK; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HEALTH CARE POLICY; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; RISK FACTOR; SMOKELESS TOBACCO; CORONARY ARTERY DISEASE; MIDDLE AGED;

ANGINA; NICOTIANA TABACUM;

ADULT; AGED; BANGLADESH; CORONARY ARTERY DISEASE; FEMALE; HUMANS; MALE; MIDDLE AGED; RISK FACTORS; TOBACCO, SMOKELESS;

EID: 84856025268     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0030584     Document Type: Article

References (49)

1. International Agency for Research on Cancer (2007) Smokeless tobacco and some tobacco-specific N-Nitrosamines. IARC Monographs on the evaluation of carcinogenic risks to humans Lyon, France International Agency for Research on Cancer pp. 1-641.
2. Lee PN, (2011) Summary of the epidemiological evidence relating snus to health. Regul Toxicol Pharmacol 59: 197-214.
3. Hergens MP, Lambe M, Pershagen G, Ye W, (2008) Risk of hypertension amongst Swedish male snuff users: a prospective study. J Intern Med 264: 187-194.
4. Gupta BK, Kaushik A, Panwar RB, Chaddha VS, Nayak KC, et al. (2007) Cardiovascular risk factors in tobacco-chewers: a controlled study. J Assoc Physicians India 55: 27-31.
5. Boffetta P, Straif K, (2009) Use of smokeless tobacco and risk of myocardial infarction and stroke: systematic review with meta-analysis. BMJ 339: b3060.
6. Rahman MA, Mahmood MA, Spurrier N, Rahman M, Leeder S, (2011) A systematic review of epidemiological studies on the association between smokeless tobacco use and coronary heart disease. J Public Health Epidemiol 3: 593-603.
7. Bolinder G, Alfredsson L, Englund A, de Faire U, (1994) Smokeless tobacco use and increased cardiovascular mortality among Swedish construction workers. Am J Public Health 84: 399-404.
8. Henley SJ, Thun MJ, Connell C, Calle EE, (2005) Two large prospective studies of mortality among men who use snuff or chewing tobacco (United States). Cancer Cause Control 16: 347-358.
9. Yatsuya H, Folsom AR, (2010) Risk of incident cardiovascular disease among users of smokeless tobacco in the Atherosclerosis Risk in Communities (ARIC) study. Am J Epidemiol 172: 600-605.
10. Teo KK, Ounpuu S, Hawken S, Pandey MR, Valentin V, et al. (2006) Tobacco use and risk of myocardial infarction in 52 countries in the INTERHEART study: a case-control study. Lancet 368: 647-658.
11. Rahman MA, Zaman MM, (2008) Smoking and smokeless tobacco consumption: possible risk factors for coronary heart disease among young patients attending a tertiary care cardiac hospital in Bangladesh. Public Health 122: 1331-1338.
12. Accortt NA, Waterbor JW, Beall C, Howard G, (2002) Chronic disease mortality in a cohort of smokeless tobacco users. Am J Epidemiol 156: 730-737.
13. Hansson J, Pedersen NL, Galanti MR, Andersson T, Ahlbom A, et al. (2009) Use of snus and risk for cardiovascular disease: results from the Swedish Twin Registry. J Intern Med 265: 717-724.
14. Janzon E, Hedblad B, (2009) Swedish snuff and incidence of cardiovascular disease. A population-based cohort study. BMC Cardiovasc Disord 9: 21.
15. Huhtasaari F, Asplund K, Lundberg V, Stegmayr B, Wester PO, (1992) Tobacco and myocardial infarction: is snuff less dangerous than cigarettes? BMJ 305: 1252-1256.
16. Huhtasaari F, Lundberg V, Eliasson M, Janlert U, Asplund K, (1999) Smokeless tobacco as a possible risk factor for myocardial infarction: a population-based study in middle-aged men. J Am Coll Cardiol 34: 1784-1790.
17. Hergens MP, Ahlbom A, Andersson T, Pershagen G, (2005) Swedish moist snuff and myocardial infarction among men. Epidemiology 16: 12-16.
18. McKee M, Gilmore A, (2007) Commentary: Smokeless tobacco: seeing the whole picture. Int J Epidemiol 36: 805-808.
19. Asplund K, (2003) Smokeless tobacco and cardiovascular disease. Prog Cardiovasc Dis 45: 383-394.
20. Gupta PC, Pednekar MS, Parkin DM, Sankaranarayanan R, (2005) Tobacco associated mortality in Mumbai (Bombay) India. Results of the Bombay Cohort Study. Int J Epidemiol 34: 1395-1402.
21. Yen AM-F, Chen L-S, Chiu Y-H, Boucher BJ, Chen TH-H, (2008) A prospective community-population-registry-based cohort study of the association between betel-quid chewing and cardiovascular disease in men in Taiwan (KCIS no. 19). Am J Clin Nutr 87: 70-78.
22. Lin W-Y, Chiu T-Y, Lee L-T, Lin C-C, Huang C-Y, et al. (2008) Betel nut chewing is associated with increased risk of cardiovascular disease and all-cause mortality in Taiwanese men. Am J Clin Nutr 87: 1204-1211.
23. Guh JY, Chen HC, Tsai JF, Chuang LY, (2007) Betel-quid use is associated with heart disease in women. Am J Clin Nutr 85: 1229-1235.
24. World Health Organization-Bangladesh (2009) Global adult tobacco survey: Bangladesh report 2009. Dhaka, Bangladesh World Health Organization-Bangladesh.
25. World Health Organization-Bangladesh (2006) Impact of tobacco related illnesses in Bangladesh. Dhaka, Bangladesh WHO-Bangladesh.
26. Flora MS, Mascie-Taylor CG, Rahman M, (2009) Gender and locality differences in tobacco prevalence among adult Bangladeshis. Tob Control 18: 445-450.
27. Efroymson D, Ahmed S, Townsend J, Alam SM, Dey AR, et al. (2001) Hungry for tobacco: an analysis of the economic impact of tobacco consumption on the poor in Bangladesh. Tob Control 10: 212-217.
28. Choudhury K, Hanifi SMA, Mahmood SS, Bhuiya A, (2007) Sociodemographic characteristics of tobacco consumers in a rural area of Bangladesh. J Health Popul Nutr 25: 456-464.
29. Gupta PC, Ray CS, (2003) Smokeless tobacco and health in India and South Asia. Respirology 8: 419-431.
30. Critchley JA, Capewell S, (2003) Mortality risk reduction associated with smoking cessation in patients with coronary heart disease: a systematic review. Journal of the American Medical Association 290: 86-97.
31. Kawachi I, Colditz GA, Stampfer MJ, Willett WC, Manson JAE, et al. (1993) Smoking cessation in relation to total mortality rates in women: a prospective cohort study. Ann Intern Med 119: 992-1000.
32. McElduff P, Dobson A, Beaglehole R, Jackson R, (1998) Rapid reduction in coronary risk for those who quit cigarette smoking. Aust N Z J Public Health 22: 787-791.
33. Infante-Rivard C, (2003) Hospital or population controls for case-control studies of severe childhood diseases? Am J Epidemiol 157: 176-182.
34. West DW, Schuman KL, Lyon JL, Robison lM, Allred R, (1984) Differences in risk estimations from a hospital and a population-based case-control study. Int J Epidemiol 13: 235-239.
35. Rose GA, (1962) The diagnosis of ischaemic heart pain and intermittent claudication in field surveys. Bull World Health Organ 27: 645-658.
36. AOAC International (2004) Official methods of analysis: Nicotine in tobacco prodcuts.
37. Stanfill SB, Connolly GN, Zhang L, Jia LT, Henningfield JE, et al. (2011) Global surveillance of oral tobacco products: total nicotine, unionised nicotine and tobacco-specific N-nitrosamines. Tob Control 20: e2.
38. Rahman M, Sakamoto J, Fukui T, (2003) Conditional versus unconditional logistic regression in the medical literature. J Clin Epidemiol 56: 101-102.
39. Wennberg P, Eliasson M, Hallmans G, Johansson L, Boman K, et al. (2007) The risk of myocardial infarction and sudden cardiac death amongst snuff users with or without a previous history of smoking. J Intern Med 262: 360-367.
40. Bolinder GM, Ahlborg BO, Lindell JH, (1992) Use of smokeless tobacco: blood pressure elevation and other health hazards found in a large-scale population survey. J Intern Med 232: 327-334.
41. Johansson S-Ea, Sundquist Ka, Qvist Jb, Sundquist Ja, (2005) Smokeless tobacco and coronary heart disease: a 12-year follow-up study. Eur J Cardiovasc Prev Rehabil 12: 387-392.
42. Haglund B, Eliasson M, Stenbeck M, Rosen M, (2007) Is moist snuff use associated with excess risk of IHD or stroke? A longitudinal follow-up of snuff users in Sweden. Scand J Public Health 35: 618-622.
43. Malson JL, Sims K, Murty R, Pickworth WB, (2001) Comparison of the nicotine content of tobacco used in bidis and conventional cigarettes. Tob Control 10: 181-183.
44. Benowitz NL, (1997) Systemic absorption and effects of nicotine from smokeless tobacco. Adv Dent Res 11: 336-341.
45. Benowitz NL, (1991) Nicotine and coronary heart disease. Trends Cardiovasc Med 1: 315-321.
46. Melikian AA, Hoffmann D, (2009) Smokeless tobacco: a gateway to smoking or a way away from smoking. Biomarkers 14 (Suppl 1): 85-89.
47. Henningfield JE, Fagerstrom KO, (2001) Swedish Match Company, Swedish snus and public health: a harm reduction experiment in progress? Tob Control 10: 253-257.
48. Foulds J, Ramstrom L, Burke M, Fagerström K, (2003) Effect of smokeless tobacco (snus) on smoking and public health in Sweden. Tob Control 12: 349-359.
49. Stepanov I, Hecht SS, Ramakrishnan S, Gupta PC, (2005) Tobacco-specific nitrosamines in smokeless tobacco products marketed in India. Int J Cancer 116: 16-19.